Jim Carrey Reveals Why He Returned for ‘Sonic the Hedgehog 3’: “I Need the Money”
The actor voices villain Dr. Robotnik and Gerald Robotnik in the upcoming sequel, zooming into theaters on Dec. 20.
Jim Carrey says he returned to 'Sonic the Hedgehog 3' because he 'needs the money'
We may see Jim Carrey in more films after his return to Hollywood with Sonic the Hedgehog 3. The iconic actor is currently doing press for the film, and at the London premiere on Monday, he shared why ...
Sonic 3 Dropped An A+ Parody Of A Christmas Classic On This Exclusive Poster, And Now I Want A Holiday Special With Jim Carrey's Robotniks
The second win comes from the fact that Sonic movie writers Pat Casey and Josh Miller are the credited team behind 2022’s ...
The Blue Blur Becomes John McClane in 'Die Hard'-Inspired 'Sonic the Hedgehog 3' Poster [Exclusive]
Sonic the Hedgehog stars in a satirical poster riffing on Die Hard, ahead of the release of Sonic the Hedgehog 3.
Jim Carrey Is Surprisingly Blunt About Why He’s Doing ‘Sonic The Hedgehog 3’
When the AP asked Carrey on Tuesday if the angels’ gold-inked script was in fact, “Sonic the Hedgehog 3,” Carrey chuckled, ...
Why did Jim Carrey return for ‘Sonic 3’? ‘I need the money, frankly’
Carrey has multiple roles in “Sonic the Hedgehog 3, ” and also portrays his villain’s grandfather, Gerald Robotnik. Director ...
First Sonic 3 clip shows Keanu Reeves’ Shadow take on Sonic, Knuckles, and Tails in electric fight scene
In the new footage, posted on Twitter by the official Sonic the Hedgehog movie account, we see Reeves' Shadow introduce ...
Keanu Reeves on finding his "inner Shadow" for "Sonic the Hedgehog 3"
Keanu Reeves says voicing Shadow in "Sonic the Hedgehog 3" gave him a special freedom to explore emotions and expression through voice.
New Sonic the Hedgehog 3 Poster Parodies This 2008 Christmas Rom Com
The publicity blitz for the theatrical release of Sonic the Hedgehog 3 is in full swing and the latest poster for the film – ...
BioWorld1d
Uniqure stock doubles as FDA points to a BLA in Huntington’s
The U.S. FDA has greenlit the first steps of Uniqure NV’s accelerated approval pathway for gene therapy AMT-130 to treat Huntington’s disease. The agency said data from the ongoing phase I/II studies ...